Vitamin D and bone health among children with epilepsy
- PMID: 20472188
- DOI: 10.1016/j.pediatrneurol.2009.12.005
Vitamin D and bone health among children with epilepsy
Abstract
The lay media and scientific literature have focused increasing attention on vitamin D deficiency and insufficiency in recent years. Low vitamin D levels confer increased an risk of abnormal bone mineralization, and are linked to poor bone health in epilepsy patients. However, vitamin D is not the only determinant of bone health in children with epilepsy. Anticonvulsant medications, in addition to features and comorbidities of epilepsy and coexisting neurologic diseases, are important factors in this complex topic. We review the basic metabolism of vitamin D in terms of bone health among children with epilepsy. We also discuss the literature regarding vitamin D and bone mineral density in this population. Finally, we suggest algorithms for screening and treating vitamin D insufficiency in these patients.
Copyright 2010 Elsevier Inc. All rights reserved.
Comment in
-
Vitamin D and bone health in children with epilepsy: fad or fact?Pediatr Neurol. 2010 Jun;42(6):394-5. doi: 10.1016/j.pediatrneurol.2010.02.001. Pediatr Neurol. 2010. PMID: 20472189 No abstract available.
Similar articles
-
Vitamin D and bone health in children with epilepsy: fad or fact?Pediatr Neurol. 2010 Jun;42(6):394-5. doi: 10.1016/j.pediatrneurol.2010.02.001. Pediatr Neurol. 2010. PMID: 20472189 No abstract available.
-
Bone consequences of epilepsy and antiepileptic medications.Semin Pediatr Neurol. 2007 Dec;14(4):196-200. doi: 10.1016/j.spen.2007.08.006. Semin Pediatr Neurol. 2007. PMID: 18070676 Review.
-
Bone and calcium metabolism and antiepileptic drugs.Clin Neurol Neurosurg. 2010 Jan;112(1):1-10. doi: 10.1016/j.clineuro.2009.10.011. Epub 2009 Nov 12. Clin Neurol Neurosurg. 2010. PMID: 19913352 Review.
-
Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone.Neurology. 2006 Dec 12;67(11):2005-14. doi: 10.1212/01.wnl.0000247107.54562.0e. Neurology. 2006. PMID: 17159108 Clinical Trial.
-
Treatment of anticonvulsant drug-induced bone disease.Epilepsy Behav. 2004 Feb;5 Suppl 2:S41-7. doi: 10.1016/j.yebeh.2003.11.028. Epilepsy Behav. 2004. PMID: 15123011
Cited by
-
Clinical and Paraclinical Screening for Celiac Disease in Children with Intractable Epilepsy.Neurol Res Int. 2021 Apr 22;2021:1639745. doi: 10.1155/2021/1639745. eCollection 2021. Neurol Res Int. 2021. PMID: 33968447 Free PMC article.
-
Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis.J Zhejiang Univ Sci B. 2015 Jul;16(7):611-21. doi: 10.1631/jzus.B1500021. J Zhejiang Univ Sci B. 2015. PMID: 26160719 Free PMC article. Review.
-
The effects of popular diets on bone health in the past decade: a narrative review.Front Endocrinol (Lausanne). 2024 Mar 26;14:1287140. doi: 10.3389/fendo.2023.1287140. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38665424 Free PMC article. Review.
-
Prevalence and Related Risk Factors of Vitamin D Deficiency in Saudi Children with Epilepsy.Children (Basel). 2022 Nov 5;9(11):1696. doi: 10.3390/children9111696. Children (Basel). 2022. PMID: 36360424 Free PMC article.
-
Inhibitor effect of paricalcitol in rat model of pentylenetetrazol-induced seizures.Naunyn Schmiedebergs Arch Pharmacol. 2016 Oct;389(10):1117-22. doi: 10.1007/s00210-016-1273-z. Epub 2016 Jul 20. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27438482
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical